VitalX Blend Side Effects

Reported VitalX Blend side effects

No data on the blend No study reporting side effects of VitalX Blend or of its ingredients given together was found in PubMed on 27 October 2026. Thiamine given by injection The FDA label for thiamine hydrochloride injection warns that serious hypersensitivity and anaphylactic reactions can occur, especially after repeated doses, and that deaths have resulted from intravenous or intramuscular thiamine. The label also lists itching and sweating, warmth, hives, weakness, nausea, restlessness, throat tightness, angioedema, cyanosis, pulmonary edema and bleeding into the gut, tenderness and hardening at the site after intramuscular use, and aluminum in the product that can reach toxic levels with prolonged use when kidney function is impaired (thiamine hydrochloride injection label, ANDA 080556, FDA, version of 9 January 2026). In a prospective study of 989 emergency patients given 1,070 intravenous doses of 100 mg, 12 reactions occurred (1.1 percent): 11 cases of transient local irritation and 1 case of generalized itching (PMID: 2757284). In the United Kingdom, available data indicated 10 anaphylactic reactions to a parenteral thiamine-containing vitamin product across an estimated 5.4 to 6.7 million patient-days of treatment (PMID: 31565743). The FDA label for Infuvite Adult, a multivitamin infusion, also lists allergic reactions to thiamine and anaphylaxis (Infuvite Adult label, FDA, version of 6 November 2024). Folic acid given by injection The FDA label for folic acid injection reports allergic sensitization after oral and injected folic acid, and warns that folic acid above 0.1 mg a day may hide pernicious anemia, because blood counts can recover while nerve damage progresses (folic acid injection label, ANDA 089202, FDA, version of 14 October 2024). Oral trials In HPS2-THRIVE, 25,673 adults with vascular disease took extended-release niacin with laropiprant or placebo for a median of 3.9 years; the combination did not reduce major vascular events and increased serious adverse events such as serious disturbances of diabetes control (3.7 percentage points more than placebo), new diabetes, infections and bleeding (PMID: 25014686). Niacin flushing comes from prostaglandin release in the skin (PMID: 19691622). For niacinamide, no noteworthy differences in adverse events between nicotinamide and placebo were found in a 386-patient skin cancer trial (PMID: 26488693), and serious adverse events did not differ in a 552-person diabetes prevention trial (PMID: 15043959). In 6 healthy adults taking 10 mg of biotin a day for a week, 9 of 23 biotin-based immunoassays gave falsely high or falsely low results (PMID: 28973622). In a 642-patient multiple sclerosis trial of high-dose biotin, the treatment caused inaccurate results on laboratory tests that use biotinylated antibodies despite mitigation steps (PMID: 33222767). A 55-patient migraine trial recorded two minor adverse events (diarrhea and frequent urination) with riboflavin and one (abdominal cramps) with placebo (PMID: 9484373).

When to continue, reduce, or stop VitalX Blend

VitalX Blend contraindications

A previous reaction to thiamine calls for caution, because the thiamine injection label warns of serious hypersensitivity and anaphylaxis, especially after repeated doses (thiamine hydrochloride injection label, FDA). Vitamin B12 deficiency is a concern because folic acid alone is improper treatment for pernicious anemia, and folic acid above 0.1 mg a day may hide it while nerve damage progresses (folic acid injection label, FDA). Diabetes is another concern: in HPS2-THRIVE, extended-release niacin given with laropiprant worsened diabetes control and increased new diabetes diagnoses (PMID: 25014686). FDA labels for injectable thiamine, folic acid and multivitamin products warn that aluminum in those products can reach toxic levels with prolonged use when kidney function is impaired (thiamine hydrochloride and folic acid injection labels, Infuvite Adult label, FDA); VitalX Blend's label does not state an aluminum content. Biotin at high oral doses (10 mg a day in the study) can cause false results in biotin-based laboratory immunoassays (PMID: 28973622).

Why vendor quality drives VitalX Blend side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

VitalX Blend side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .